Literature DB >> 4971733

Nitrolglycerin as a provocative agent in cluster headache.

K Ekbom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4971733     DOI: 10.1001/archneur.1968.00480050057005

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  35 in total

Review 1.  Cluster headache and its variants.

Authors:  J M Pearce
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

Review 2.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Editorial: Cluster headache.

Authors: 
Journal:  Br Med J       Date:  1975-11-22

4.  A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches.

Authors:  Oliver Summ; Anna P Andreou; Simon Akerman; Peter J Goadsby
Journal:  J Headache Pain       Date:  2010-10-27       Impact factor: 7.277

5.  Calcium entry blocker: treatment in acute pain in cluster headache patients.

Authors:  A Boiardi; M Gemma; E Porta; C Peccarisi; G Bussone
Journal:  Ital J Neurol Sci       Date:  1986-10

Review 6.  Nitric oxide-related drug targets in headache.

Authors:  Jes Olesen
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 7.  Update on the diagnosis and management of trigemino-autonomic headaches.

Authors:  Arne May
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 8.  Mechanism of action of indomethacin in indomethacin-responsive headaches.

Authors:  Oliver Summ; Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2013-04

Review 9.  Focus on headache as an adverse reaction to drugs.

Authors:  Anna Ferrari; Luca Spaccapelo; Daniela Gallesi; Emilio Sternieri
Journal:  J Headache Pain       Date:  2009-06-04       Impact factor: 7.277

Review 10.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.